Home LiteratureArticle Details
PMID: 17768662 Published · ppublish English Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.

Annals of surgical oncology ·Vol. 14 ·No. 11 ·2007-11-00 ·Pages 3251-9

Xu HT, Wei Q, Liu Y, Yang LH, Dai SD, Han Y, Yu JH, Liu N, Wang EH

Abstract

T cell factor 4 (TCF-4) mediates a nuclear response to wingless/int (Wnt) signals by interacting with beta-catenin. Axis inhibition protein (axin) is an important negative regulator of the Wnt signaling pathway. Our aims were to examine the relationship between axin and TCF-4 and to explore the effects of axin on the development of lung cancer. Expression levels of axin and TCF-4 were examined in 107 lung cancer specimens by immunohistochemistry. The axin gene was transfected into lung cancer BE1 cells. The expression levels of axin, beta-catenin, and TCF-4 were detected with immunofluorescence and reverse transcription-polymerase chain reaction (RT-PCR) experiments. Apoptosis, proliferation, and the invasive ability of lung cancer cells were examined using flow cytometry, 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT), and Matrigel invasive assays. Preserved axin expression correlated negatively with TCF-4 expression (P = .031). Axin expression differed with respect to degree of differentiation (P = .025) and histological tumor type (P = .031). TCF-4 expression differed relative to tumor, node metastasis (TNM) stage (P = .024). BE1 cells transfected with axin (BE1-axin cells) exhibited a significant decrease in TCF-4 expression. The level of apoptosis in BE1-axin cells was significantly increased, while the proliferative and invasive abilities of BE1-axin cells were decreased. These results suggest that reduced expression of axin or augmented expression of TCF-4 is associated with the malignant behavior of lung cancers. Overexpression of axin can downregulate expression of TCF-4 and can inhibit the ability of lung cancer cells to proliferate and invade.

MeSH Terms
Adenocarcinoma/genetics,metabolism,pathology Adult Aged Aged, 80 and over Apoptosis Axin Protein Carcinoma, Giant Cell/genetics,metabolism,pathology Carcinoma, Squamous Cell/genetics,metabolism,pathology Cell Differentiation Cell Movement Cell Proliferation Female Fluorescent Antibody Technique Gene Expression Regulation, Neoplastic Humans Lung Neoplasms/genetics,metabolism,pathology Male Middle Aged Neoplasm Invasiveness Repressor Proteins/genetics,metabolism Reverse Transcriptase Polymerase Chain Reaction Signal Transduction TCF Transcription Factors/genetics,metabolism Transcription Factor 7-Like 2 Protein Transcription, Genetic Tumor Cells, Cultured beta Catenin/metabolism
Chemicals
Axin Protein Repressor Proteins TCF Transcription Factors TCF7L2 protein, human Transcription Factor 7-Like 2 Protein beta Catenin
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Xu Hong-Tao
Department of Pathology, College of Basic Medical Sciences, China Medical University, Shenyang, 110001, China.
Wei Qiang
Liu Yang
Yang Lian-He
Dai Shun-Dong
Han Yang
Yu Juan-Han
Liu Nan
Wang En-Hua
Article Info
Journal
Annals of surgical oncology
Abbr.
Ann Surg Oncol
ISSN
1534-4681
Published
2007-11-00
Epub
2007-00-01
Pages
3251-9
Language
English
Region
United States
NLM ID
9420840
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com